China Stem Cells Market Size & Outlook, 2024-2030
China stem cells market, 2018-2030 (US$M)
Related Markets
China stem cells market highlights
- The China stem cells market generated a revenue of USD 917.0 million in 2024 and is expected to reach USD 2,551.7 million by 2030.
- The China market is expected to grow at a CAGR of 18.6% from 2025 to 2030.
- In terms of segment, adult stem cells was the largest revenue generating product in 2024.
- Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
Stem cells market data book summary
| Market revenue in 2024 | USD 917.0 million |
| Market revenue in 2030 | USD 2,551.7 million |
| Growth rate | 18.6% (CAGR from 2024 to 2030) |
| Largest segment | Adult stem cells |
| Fastest growing segment | Induced Pluripotent Stem Cells |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, China accounted for 5.6% of the global stem cells market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China stem cells market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,551.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stem Cells Market Scope
Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.75% in 2024. Horizon Databook has segmented the China stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
China is anticipated to witness the fastest growth in the stem cells market during the forecast period. This is because the region is expanding the scope of stem cell research and developing numerous scientific advancements in medical applications.
In May 2021, a study published by National Library of Medicine stated that there are approximately 13 well-established stem cell research centers with over 400 PhD-level professionals across Mainland. The investment resulted in increasing publications on stem cells.
All four banks are actively involved in improving and providing enhanced applications of the stem cell market across the country. Thus, with social, legal, and government support, China is expected to witness rapid growth and advances in the global stem cell market.
Reasons to subscribe to China stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China stem cells market databook
-
Our clientele includes a mix of stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China stem cells market , including forecasts for subscribers. This country databook contains high-level insights into China stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China stem cells market size, by product, 2018-2030 (US$M)
China Stem Cells Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
